Other products from "WILTROM CO., LTD. (CHUTUNG)"
No Primary DI Version or Model Catalog Number Device Description Product Code Product Code Name Device Class Brand Name
1 04719875720147 BC-G29(2.0-3.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
2 04719875720130 BC-G28(2.0-3.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
3 04719875720123 BC-G27(2.0-3.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
4 04719875720116 BC-G26(1.0-2.0mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
5 04719875720109 BC-G25(1.0-2.0mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
6 04719875720093 BC-G24(1.0-2.0mm,15c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
7 04719875720086 BC-G23(0.5-1.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
8 04719875720079 BC-G22(1.0-2.0mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
9 04719875720055 BC-G20(2.0-3.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
10 04719875720048 BC-G19 (1.0-2.0mm,1.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
11 04719875720031 BC-G18(1.0-2.0mm,1.0g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
12 04719875720024 BC-G17(1.0-2.0mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
13 04719875720017 BC-G16(1.0-2.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
14 04719875720000 BC-G15(0.5-1.0mm,1g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
15 04719873029990 BC-G14(0.5-1.0mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
16 04719873029983 BC-G13(0.5-1.0mm,0.25g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
17 04719873029976 BC-G12(0.25-0.5mm,1g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
18 04719873029969 BC-G11(0.25-0.5mm,0.5g) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
19 04719873029945 BC-G09(0.5-1.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
20 04719873029938 BC-G08(0.5-1.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
21 04719873029921 BC-G07(1.0-2.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
22 04719873029914 BC-G06(1.0-2.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
23 04719873029907 BC-G05(2.0-3.0mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
24 04719873029891 BC-G04(2.0-3.0mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
25 04719873029884 BC-G03(0.5-1.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
26 04719873029877 BC-G02(1.0-2.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
27 04719873027729 BC-G01(2.0-3.0mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
28 04719873027712 BC-B12 (5x5x10mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
29 04719873027705 BC-B11 (5x5x10mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
30 04719873027699 BC-B10 (5x5x20mm,30c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
31 04719873027682 BC-B09 (5x5x20mm,20c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
32 04719873027668 BC-B07(5x5x20mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
33 04719873027651 BC-B06(5x5x20mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
34 04719873027644 BC-B05(5x5x10mm,10c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
35 04719873027637 BC-B04(5x5x10mm,7c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
36 04719873027620 BC-B03(5x5x10mm,5c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
37 04719873027613 BC-B02(5x5x10mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
38 04719873027606 BC-B01(5x5x20mm,2c.c.) Bicera® Resorbable Bone Substitute is a bioceramic medical device that its compo Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP). Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process. MQV Filler, Bone Void, Calcium Compound 2 Bicera® Resorbable Bone Substitute
Other products with the same Product Code "MQV"
No Primary DI Version or Model Catalog Number Device Description Brand Name Organization Name
1 04250971422097 T671CB15-3-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 3 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
2 04250971422080 T671CB15-2-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
3 04250971422073 T671CB15-1-1 6.1/7.1CB1.5 Synthacer®/Syntricer® 300 Ceraball®, mixture of HA and TCP, diameter 1.5 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
4 04250971422066 T672CB03-5-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
5 04250971422059 T672CB03-2-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
6 04250971422042 T672CB03-1-1 6.2/7.2CB03 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 3 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
7 04250971422035 T672CB0406-30-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
8 04250971422028 T672CB0406-20-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
9 04250971422011 T672CB0406-10-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
10 04250971422004 T672CB0406-5-1 6.2/7.2CB0406 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diamete Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, mixture with diameters 4 mm and 6 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
11 04250971421991 T672CB06-10-1 6.2/7.2CB06 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 6 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
12 04250971421984 T672CB06-5-1 6.2/7.2CB06 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 6 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
13 04250971421977 T672CB04-10-1 6.2/7.2CB04 Synthacer®/Syntricer® 600 Ceraball®, mixture of HA and TCP, diameter 4 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
14 04250971421960 T672G03-30-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
15 04250971421953 T672G03-20-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
16 04250971421946 T672G03-15-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
17 04250971421939 T672G03-10-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
18 04250971421922 T672G03-5-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
19 04250971421915 T672G03-2-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
20 04250971421908 T672G03-1-1 6.2/7.2G03 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 2.6 - 4.8 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
21 04250971421892 T672G02-30-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
22 04250971421885 T672G02-20-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
23 04250971421878 T672G02-15-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
24 04250971421861 T672G02-10-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
25 04250971421854 T672G02-5-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
26 04250971421847 T672G02-2-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
27 04250971421830 T672G02-1-1 6.2/7.2G02 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2 Synthacer®/Synthacer® 600 granules, mixture of HA and TCP, particle size 1.0 - 2.5 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
28 04250971421823 T672G01-30-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 30 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
29 04250971421816 T672G01-20-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 20 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
30 04250971421809 T672G01-15-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 15 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
31 04250971421793 T672G01-10-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 10 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
32 04250971421786 T672G01-5-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 5 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
33 04250971421779 T672G01-2-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 2 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
34 04250971421762 T672G01-1-1 6.2/7.2G01 Synthacer®/Synthacer® 600 powder, mixture of HA and TCP, particle size 0.1 - 0.9 mm, 1 ml Synthacer/Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
35 04250971421755 T71CB15-3-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 3 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
36 04250971421748 T71CB15-2-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 2 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
37 04250971421731 T71CB15-1-1 7.1CB1.5 Syntricer® 300 Ceraball®, TCP, diameter 1.5 mm, 1 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
38 04250971421724 T72CB03-5-1 7.2CB03 Syntricer® 600 Ceraball®, TCP, diameter 3 mm, 5 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
39 04250971421717 T72CB03-2-1 7.2CB03 Syntricer® 600 Ceraball®, TCP, diameter 3 mm, 2 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
40 04250971421700 T72CB0406-30-1 7.2CB0406 Syntricer® 600 Ceraball®, TCP, mixture with diameters 4 mm and 6 mm, 30 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
41 04250971421694 T72CB0406-20-1 7.2CB0406 Syntricer® 600 Ceraball®, TCP, mixture with diameters 4 mm and 6 mm, 20 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
42 04250971421687 T72CB0406-10-1 7.2CB0406 Syntricer® 600 Ceraball®, TCP, mixture with diameters 4 mm and 6 mm, 10 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
43 04250971421670 T72CB06-10-1 7.2CB06 Syntricer® 600 Ceraball®, TCP, diameter 6 mm, 10 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
44 04250971421663 T72CB04-10-1 7.2CB04 Syntricer® 600 Ceraball®, TCP, diameter 4 mm, 10 ml Syntricer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
45 04250971421656 T61CB15-3-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 3 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
46 04250971421649 T61CB15-2-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 2 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
47 04250971421632 T61CB15-1-1 6.1CB1.5 Synthacer® 300 Ceraball®, HA, diameter 1.5 mm, 1 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
48 04250971421625 T62CB03-5-1 6.2CB03 Synthacer® 600 Ceraball®, HA, diameter 3 mm, 5 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
49 04250971421618 T62CB03-2-1 6.2CB03 Synthacer® 600 Ceraball®, HA, diameter 3 mm, 2 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT
50 04250971421601 T62CB0406-30-1 6.2CB0406 Synthacer® 600 Ceraball®, HA, mixture with diameters 4 mm and 6 mm, 30 ml Synthacer MEDARTIS MEDIZINPRODUKTE UND FORSCHUNG AKTIENGESELLSCHAFT